News | April 08, 2013

Best Medical Expands Radiation Therapy Offers With New Acquisitions

 Best Medical Expansion Radiation Therapy Acquisitions

 

April 8, 2013 — TeamBest companies are planning for a major expansion by diversifying its area of expertise and product lines, to meet the growing demands of an increasing and aging population. Earlier this year, Best Medical International (BMI) purchased Envisioneering Medical Technologies’ assets including TargetScan Touch, an ultrasound based stereotactic biopsy guidance and tumor localization system. TargetScan data can be used to generate a predictive model of tumor locations and provide for micro-invasive curative techniques using EBRT (external beam radiation therapy) or brachytherapy or combination. Because of its ability to target and record biopsy locations the TargetScan Touch can provide for prostate cancer management protocols such as active surveillance and focal therapy. The acquisition of Envisioneering’s assets is part of TeamBest’s commitment to offer "Total Solutions for the Treatment of Prostate Cancer." This enhances the BMI portfolio of brachytherapy products, such as gold, iodine, iridium and palladium seeds and accessories for accurate diagnosis, treatment planning and treatment for the best possible clinical outcome. BMI now is the only company in the world providing these complete and comprehensive solutions for prostate cancer diagnosis and treatment.

One of the TeamBest companies, Best NOMOS, invented the technology known as IMRT (intensity modulated radiation therapy), and it is the global standard for treating cancer patients. Best NOMOS continues to invest millions of dollars annually to expand and upgrade these and other technologies to be in the forefront of cancer diagnosis and treatment.

Recently, the U.S. Food & Drug Administration (FDA) has provided marketing approval for Best Iodine seeds for breast tumor localization for more accurate cancer diagnosis and treatment. With a continued emphasis on Best Total Solutions, TeamBest will offer a complete range of products for comprehensive cancer management, from brachytherapy, external beam teletherapy, and proton to carbon, particle therapy. Presently TeamBest companies are bidding on projects worth $500 million or more, globally.

Best Vascular, another TeamBest company, manufactures the Novoste Beta-Cath System, an intravascular brachytherapy device used by cardiologists to treat in-stent restenosis in coronary arteries. Best Vascular is the only company in the world providing this unique life saving technology and it continues to pursue clinical research and trials for other indications.

Best Cure Foundation was established in 2007 to make quality healthcare and education affordable and accessible globally. The CURE Institute of Health Physics, a division of Best Cure Foundation, a non-profit organization, has been established to help train and assist those providing services in Medical and Non-medical (Industrial) enterprises.

TeamBest continues to provide Best Fellowships to residents and other medical professionals to attend medical conferences and workshops in their area of expertise.

TeamBest recently formed another new company, Best Dosimetry Services, to provide personnel dosimetry services for medical and non-medical workers handling hazardous materials.

One of TeamBest's new companies is Best NDT (Non Destructive Testing), which offers a wide range of products globally for the oil and gas pipeline industry such as isotopes, pipe crawlers, cameras and other devices and accessories, including quality assurance and quality control products.

USA and Canada alone will spend nearly $10 to $15 billion per month over the next two decades in oil and gas exploration, infrastructure, production and distribution. Kitsault Energy, established in 2013, is planning for a dedicated energy corridor/natural gas pipeline from North East British Columbia (Canada), Fort Nelson to Kitsault Resort (one of TeamBest companies), Energy Export Terminal and LNG (Liquefied Natural Gas) Facility at Kitsault, BC Canada. This is a multi phase program, spanning 8 to 10 years. The first phase is expected to cost $5 billion, the second phase $5 billion, third phase $10 billion, and the fourth phase will be approximately $10 to $15 billion.

The Best Global Talent Agency was established recently to meet the growing need of various industries for a highly trained and skilled labor force, and to provide training to Aboriginal First Nations Communities and others for these high paying jobs.

There are other expansion plans, all of which require huge investments and the need for highly trained and skilled staff. TeamBest has grown from a few employees to more than 500 employees with several offices in the United States, Canada, Europe and India and continue to add more new staff every month. TeamBest is investing $10 million or more every year in new product development, clinical research and trials. TeamBest plans to continue this for quite some time to expand the product portfolio globally.

For more information: www.teambest.com

 

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init